299 related articles for article (PubMed ID: 26999933)
1. [Possibilities of boron neutron capture therapy in the treatment of malignant brain tumors].
Kanygin VV; Kichigin AI; Gubanova NV; Taskaev SY
Vestn Rentgenol Radiol; 2015; (6):36-42. PubMed ID: 26999933
[TBL] [Abstract][Full Text] [Related]
2. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
Barth RF; Soloway AH; Brugger RM
Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy of brain tumors: an emerging therapeutic modality.
Barth RF; Soloway AH; Goodman JH; Gahbauer RA; Gupta N; Blue TE; Yang W; Tjarks W
Neurosurgery; 1999 Mar; 44(3):433-50; discussion 450-1. PubMed ID: 10069580
[TBL] [Abstract][Full Text] [Related]
5. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
[TBL] [Abstract][Full Text] [Related]
6. Boron neutron capture therapy of cancer: current status and future prospects.
Barth RF; Coderre JA; Vicente MG; Blue TE
Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
[TBL] [Abstract][Full Text] [Related]
7. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
8. Boron neutron capture therapy of primary and metastatic brain tumors.
Barth RF; Soloway AH
Mol Chem Neuropathol; 1994; 21(2-3):139-54. PubMed ID: 8086033
[TBL] [Abstract][Full Text] [Related]
9. Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT).
Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
Appl Radiat Isot; 2014 Jun; 88():20-2. PubMed ID: 24480727
[TBL] [Abstract][Full Text] [Related]
10. The basis and advances in clinical application of boron neutron capture therapy.
He H; Li J; Jiang P; Tian S; Wang H; Fan R; Liu J; Yang Y; Liu Z; Wang J
Radiat Oncol; 2021 Nov; 16(1):216. PubMed ID: 34743756
[TBL] [Abstract][Full Text] [Related]
11. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro evaluation of thiododecaborated α, α- cycloalkylamino acids for the treatment of malignant brain tumors by boron neutron capture therapy.
Hattori Y; Kusaka S; Mukumoto M; Ishimura M; Ohta Y; Takenaka H; Uehara K; Asano T; Suzuki M; Masunaga S; Ono K; Tanimori S; Kirihata M
Amino Acids; 2014 Dec; 46(12):2715-20. PubMed ID: 25173737
[TBL] [Abstract][Full Text] [Related]
13. Analysis of boron distribution in vivo for boron neutron capture therapy using two different boron compounds by secondary ion mass spectrometry.
Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Okabe M; Kirihata M; Ono K; Kuroiwa T
Radiat Res; 2007 Jan; 167(1):102-9. PubMed ID: 17214510
[TBL] [Abstract][Full Text] [Related]
14. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study.
Kankaanranta L; Seppälä T; Koivunoro H; Välimäki P; Beule A; Collan J; Kortesniemi M; Uusi-Simola J; Kotiluoto P; Auterinen I; Serèn T; Paetau A; Saarilahti K; Savolainen S; Joensuu H
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):369-76. PubMed ID: 21236605
[TBL] [Abstract][Full Text] [Related]
15. Applications and perspectives of boron-enriched nanocomposites in cancer therapy.
Yinghuai Z; Hosmane NS
Future Med Chem; 2013 Apr; 5(6):705-14. PubMed ID: 23617432
[TBL] [Abstract][Full Text] [Related]
16. Boron concentrations in brain during boron neutron capture therapy: in vivo measurements from the phase I trial EORTC 11961 using a gamma-ray telescope.
Verbakel WF; Sauerwein W; Hideghety K; Stecher-Rasmussen F
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):743-56. PubMed ID: 12573762
[TBL] [Abstract][Full Text] [Related]
17. Boron neutron capture therapy for malignant brain tumors.
Miyatake SI; Wanibuchi M; Hu N; Ono K
J Neurooncol; 2020 Aug; 149(1):1-11. PubMed ID: 32676954
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
19. Boron neutron capture therapy for glioblastoma multiforme.
van Rij CM; Wilhelm AJ; Sauerwein WA; van Loenen AC
Pharm World Sci; 2005 Apr; 27(2):92-5. PubMed ID: 15999918
[TBL] [Abstract][Full Text] [Related]
20. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]